Product Information
VARDENAFIL HCL 20 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $2.7928 per EA under NDC 62332023930. Its NADAC has been published 268 times since Aug 18, 2021.
FDA first approved this application on Aug 4, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the VARDENAFIL HYDROCHLORIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332023930
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VARDENAFIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214031FDA Approved
8/4/2020
TE Code
AB
On Market Since
8/5/2020
Pharmacological Classes
Price Statistics
The NADAC for VARDENAFIL HCL 20 MG TABLET has been published 268 times since Aug 18, 2021, and over the history we have for it it has declined 85.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7928 per EA |
|---|---|
| All-time high | $19.4457 (Oct 13, 2021) |
| All-time low | $2.0217 (Jul 17, 2024) |
| 52-week high | $3.0727 |
| 52-week low | $2.3238 |
| Median price | $2.8366 |
| Average price | $3.8534 |
| Largest weekly change | -59.2% (Oct 20, 2021) |
| Weeks tracked | 268 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the VARDENAFIL HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VARDENAFIL HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARDENAFIL HCL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VARDENAFIL HCL 20 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $2.7928 per EA (NDC 62332023930), effective Sep 30, 2026.
How has the price of VARDENAFIL HCL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for VARDENAFIL HCL 20 MG TABLET has declined 85.6%. It has been tracked across 268 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for VARDENAFIL HCL 20 MG TABLET?
Since Aug 18, 2021, the NADAC for VARDENAFIL HCL 20 MG TABLET has ranged from a low of $2.0217 (Jul 17, 2024) to a high of $19.4457 (Oct 13, 2021), with a median of $2.8366 per EA.
Are there cheaper alternatives to VARDENAFIL HCL 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VARDENAFIL HCL 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VARDENAFIL HCL 20 MG TABLET?
VARDENAFIL HCL 20 MG TABLET (NDC 62332023930) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.